Skip to main content
. 2024 Oct 23;7(4):ooae109. doi: 10.1093/jamiaopen/ooae109

Table 2.

Summary of meeting sessions.

Meeting session type and title Description
Day 1
Patient Roundtable: Patient Perspectives on CDS and PC CDS Moderated roundtable discussion on PC CDS with patients and patient advocates.
Panel Presentation: Measuring PC CDS Moderated panel presentation highlighting efforts to advance measurement for PC CDS from the Innovation Center; Scaling, Measurement and Dissemination Workgroup; and Outcomes and Objectives Workgroup. The 3 presentations were:
  • Measuring PC CDS Performance: A Unified Framework

  • Scaling, Measurement, and Dissemination of CDS Workgroup Measurement Products

  • Measuring Outcomes of PC CDS

Keynote Presentation Presentation on cultivating trust between the patient and provider or system.
Presentation: Remarks from AHRQ Director Remarks from the Director of AHRQ about the healthcare system’s role in PC CDS.
Panel Presentation: Patient Preferences and PC CDS Moderated panel presentation on describing patient preferences and how it informs PC CDS. The 3 presentations were:
  • Taxonomy for Patient Preferences that are Relevant to PC CDS

  • Current State of Standards to Support the Capture of Patient Preferences for PC CDS

  • United States Core Data for Interoperability Advancing Patient Preference in Health Information Technology

Panel Presentation: Innovation Center Dashboard Demonstration Demonstrations of 2 types of dashboards, one focused on patient-generated health data and the other on visualizing PC CDS performance metrics and aggregated patient-reported outcomes. The 3 presentations were:
  • Charts on FHIR: Open-Source Software for Visualizing Patient-generated Health Data

  • Patient Health Questionnaire Dashboard and Inflammatory Bowel Disease Dashboard

  • PC CDS Dashboards Usability

Day 2
Panel Presentation: The PC CDS Standards and Regulatory Landscape Moderated panel presentation discussing the current PC CDS standards and regulatory landscape and the implications for PC CDS researchers and developers as it relates to patient facing CDS. The 3 presentations were:
  • Standards for PC CDS

  • Food and Drug Administration’s Clinical Decision Support Software Guidance

  • Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology’s PC CDS Standards and Regulatory Landscape

Breakout Session: Advancing PC CDS Moderated breakout groups discussing challenges, strengths, and opportunities for PC CDS. This session included a 10-min orientation, 60-min discussion in 5 groups, and a report-out of each group’s discussions.
Panel Presentation: Trust in PC CDS: From Design to Implementation Moderated panel presentation highlighting CDSiC work to advance trust in PC CDS. The 2 presentations were:
  • Improving PC CDS Source Credibility

  • Improving PC CDS through Co-Design

Abbreviations: AHRQ = agency for healthcare research and quality, CDS = clinical decision support, CDSiC = Clinical Decision Support Innovation Collaborative, FHIR = fast healthcare interoperability resources, PC CDS = patient-centered clinical decision support.